X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2421) 2421
Publication (165) 165
Book Review (20) 20
Magazine Article (19) 19
Book Chapter (14) 14
Conference Proceeding (12) 12
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematinics - therapeutic use (2437) 2437
humans (2382) 2382
female (1216) 1216
anemia - drug therapy (1136) 1136
erythropoietin - therapeutic use (1109) 1109
index medicus (1084) 1084
male (1064) 1064
anemia (899) 899
middle aged (819) 819
anemia - etiology (727) 727
aged (712) 712
recombinant proteins (649) 649
adult (568) 568
epoetin alfa (557) 557
treatment outcome (525) 525
urology & nephrology (488) 488
erythropoietin (473) 473
recombinant-human-erythropoietin (414) 414
hematinics - adverse effects (389) 389
erythropoietin - analogs & derivatives (372) 372
darbepoetin alfa (370) 370
hemoglobins - metabolism (357) 357
hematinics - administration & dosage (337) 337
kidney failure, chronic - complications (324) 324
oncology (322) 322
hemoglobin (313) 313
anemia - blood (296) 296
renal dialysis (290) 290
chronic kidney-disease (285) 285
epoetin-alpha (282) 282
hemoglobins - analysis (279) 279
risk factors (278) 278
kidney failure, chronic - therapy (263) 263
quality-of-life (263) 263
quality of life (262) 262
aged, 80 and over (259) 259
double-blind (258) 258
mortality (252) 252
retrospective studies (244) 244
care and treatment (226) 226
hemodialysis (217) 217
medicine, general & internal (217) 217
blood transfusion (216) 216
neoplasms - complications (215) 215
prospective studies (215) 215
folic acid - therapeutic use (214) 214
time factors (213) 213
anemia - therapy (212) 212
cancer (212) 212
chronic kidney disease (210) 210
hemodialysis-patients (210) 210
neoplasms - drug therapy (209) 209
anemia - chemically induced (208) 208
anemia, iron-deficiency - drug therapy (206) 206
pharmacology & pharmacy (206) 206
antineoplastic agents - adverse effects (201) 201
iron - therapeutic use (194) 194
erythropoiesis-stimulating agents (191) 191
erythropoietin - adverse effects (189) 189
therapy (187) 187
renal insufficiency, chronic - complications (175) 175
erythropoietin - administration & dosage (174) 174
hematology (173) 173
iron (173) 173
practice guidelines as topic (171) 171
adolescent (167) 167
chemotherapy (164) 164
chronic disease (160) 160
darbepoetin-alpha (159) 159
nephrology (159) 159
anemia - complications (155) 155
ferric compounds - therapeutic use (151) 151
medicine & public health (150) 150
randomized controlled trials as topic (145) 145
dose-response relationship, drug (143) 143
hematinics - economics (143) 143
united states (143) 143
health aspects (142) 142
erythropoiesis - drug effects (141) 141
anaemia (140) 140
prevalence (140) 140
dialysis (139) 139
animals (136) 136
intravenous iron (134) 134
kidney failure, chronic - blood (134) 134
renal dialysis - adverse effects (131) 131
anemia - diagnosis (130) 130
drug therapy (129) 129
recombinant proteins - therapeutic use (129) 129
chronic kidney failure (128) 128
transplantation (127) 127
biomarkers - blood (126) 126
drug administration schedule (126) 126
ferritins - blood (125) 125
research (123) 123
management (121) 121
trial (120) 120
young adult (120) 120
analysis (119) 119
hematinics - pharmacology (119) 119
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2236) 2236
Spanish (46) 46
French (44) 44
Italian (19) 19
German (18) 18
Croatian (15) 15
Japanese (15) 15
Russian (14) 14
Hungarian (11) 11
Polish (6) 6
Dutch (3) 3
Portuguese (3) 3
Chinese (2) 2
Czech (2) 2
Swedish (2) 2
Bulgarian (1) 1
Danish (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Supportive Care in Cancer, ISSN 0941-4355, 1/2016, Volume 24, Issue 1, pp. 67 - 75
Journal Article
Journal Article
British Journal of Surgery, ISSN 0007-1323, 02/2017, Volume 104, Issue 3, pp. 214 - 221
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 21, pp. 2019 - 2032
Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. This... 
ERYTHROPOIESIS-STIMULATING AGENTS | RANDOMIZED-TRIALS | RISK-FACTOR | ANEMIA CORRECTION | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | HEMODIALYSIS-PATIENTS | RECOMBINANT HUMAN ERYTHROPOIETIN | EPOETIN-ALPHA | UMCG Approved | STAGE RENAL-DISEASE | MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | CARDIOVASCULAR OUTCOMES | INTERVENTION | Erythropoietin - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Renal Insufficiency, Chronic - complications | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Stroke - chemically induced | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Anemia - etiology | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Hematinics - therapeutic use | Kaplan-Meier Estimate | Neoplasms - mortality | Hematinics - adverse effects | Renal Insufficiency, Chronic - blood | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Aged | Darbepoetin alfa | Hemoglobins - analysis | Type 2 diabetes | Complications and side effects | Outcome and process assessment (Health Care) | Drug therapy | Cardiovascular diseases | Risk factors | Hypertension | Hypotheses | Transplants & implants | Patient safety | Kidney diseases | Diabetes | Blood diseases | Index Medicus | Abridged Index Medicus
Journal Article